How Much Can Patients Save on Wegovy Treatment?
Wegovy (semaglutide) costs $1,349 per month without insurance in the US, based on list price from Novo Nordisk.[1] Patient savings depend on insurance coverage, manufacturer discounts, and pharmacy options, often reducing out-of-pocket costs to $0–$25 monthly for eligible users.
Wegovy's Savings Card and Copay Assistance
Novo Nordisk's Savings Card covers up to $225 per 28-day fill (four pens), capping copays at $25 for commercially insured patients. Eligibility requires no government insurance like Medicare; maximum savings reach $2,700 annually.[2] Over 80% of users pay $25 or less per month via this program.
Insurance Coverage and Out-of-Pocket Costs
- Commercial insurance: Most plans cover Wegovy for obesity (BMI ≥30 or ≥27 with comorbidities), with copays averaging $50–$100 monthly after savings card. Prior authorizations are common.
- Medicare/Medicaid: Medicare Part D covers it under obesity benefit (post-2024 changes), but copays range $100–$400 monthly without extra help. Medicaid varies by state.
- Uninsured patients: Savings card ineligible; full price applies, though some pharmacies offer $1,100–$1,200 cash discounts.
Real-world data shows average patient cost at $25–$50 monthly with assistance.[3]
Compared to Ozempic and Other Weight Loss Drugs
Wegovy shares semaglutide with Ozempic (diabetes-labeled, $935/month list). Off-label Ozempic use costs less due to broader coverage, saving patients $400+ monthly versus Wegovy without aid. Vs. Zepbound (tirzepatide, $1,060/month), savings cards similarly cap at $25.[4]
| Drug | List Price/Month | Typical Patient Cost with Aid |
|------|------------------|-------------------------------|
| Wegovy | $1,349 | $0–$25 |
| Ozempic | $935 | $10–$25 |
| Zepbound | $1,060 | $0–$25 |
Biosimilars and Future Price Drops
No Wegovy biosimilars yet; Novo Nordisk's semaglutide patents expire 2031–2036.[5]DrugPatentWatch.com. Entry could cut prices 30–80%, like Humira savings. Compounded semaglutide (non-FDA approved) offers $200–$400/month but risks quality issues and legality.
What If You're Ineligible for Discounts?
Patients over savings card limits or uninsured pay full price. Alternatives include patient assistance programs (income-based, free for <400% FPL) or switching to generics/orlistat ($10–$50/month).[6] Check GoodRx for coupons dropping Wegovy to $1,200 cash.
[1]: Novo Nordisk pricing, novomedlink.com
[2]: Wegovy Savings Card terms, wegovy.com/savings
[3]: IQVIA claims data 2024
[4]: Eli Lilly Zepbound pricing
[5]: DrugPatentWatch.com
[6]: NovoCare patient assistance